Cargando…

Protein structure-based drug design: applications, limitations and future developments

Detalles Bibliográficos
Autor principal:	Hillisch, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236214/ http://dx.doi.org/10.1186/1752-153X-2-S1-S15

Ejemplares similares

Targeting protein dynamics in drug design
por: Wade, Rebecca C
Publicado: (2013)

A computational protocol to fragment-based drug design at PDB scale
por: Moriaud, F, et al.
Publicado: (2008)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

On the validity of popular assumptions in computational drug design
por: Klebe, Gerhard
Publicado: (2011)

Chemoinformatics in drug development
por: Groom, Colin R
Publicado: (2012)

Issues in structure-modifying osteoarthritis drug development: new insights regarding radiographic clinical trial methods
por: Beary, JF, et al.
Publicado: (2004)

Designing nanoparticles for delivery of neurotrophic proteins
por: Angelova, Angelina, et al.
Publicado: (2013)

Generation of structure-based pharmacophores using energetic analysis – application on fragment docking
por: Loving, Kathryn, et al.
Publicado: (2011)

Health technology assessment: oncology drugs with orphan designation as an example
por: Wild, Claudia
Publicado: (2010)

Mystery shopping in community drug shops: research as development in rural Tanzania
por: Dillip, Angel, et al.
Publicado: (2012)

Design considerations in the development of a core outcome set
por: Harman, Nicola, et al.
Publicado: (2013)

Optimising the design and evaluation of pilot work to inform the main trial: a review of current evidence and consideration of future practices
por: O'Connell Francischetto, Elaine, et al.
Publicado: (2013)

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env
por: Wheatley, AK, et al.
Publicado: (2009)

Clinical trials in drug development: the Brazilian experience
por: de Morais, Odorico
Publicado: (2014)

What can available randomised controlled trials evaluating monitoring strategies tell us about the design and analysis of future trials?
por: Dinnes, Jacqueline, et al.
Publicado: (2011)

How pre-trial qualitative research can change proposed RCT design: a case study and implications for future research
por: Rooshenas, Leila, et al.
Publicado: (2015)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

A multi-arm multi-stage design for binary outcomes and application to tuberculosis
por: Bratton, Daniel, et al.
Publicado: (2013)

Natural product-likeness score and its applications in the drug discovery process
por: Ertl, Peter, et al.
Publicado: (2008)

Implementing evidence-based medicine practice in Indonesia: before, now, and the future
por: Sastroasmoro, Sudigdo
Publicado: (2013)

Limitations of muscle biopsy in Pompe disease
por: Vissing, John
Publicado: (2013)

Limits to the scalability of cortical network models
por: van Albada, Sacha J, et al.
Publicado: (2015)

Limitations of the manual supination resistance test
por: Bennett, Paul J, et al.
Publicado: (2015)

DrugScore(FP): profiling protein-ligand interactions using fingerprint simplicity paired with knowledge-based potential fields
por: Pfeffer, Patrick, et al.
Publicado: (2008)

Modeling of nanomaterials: recent applications and new tools development
por: Goldbeck-Wood, G
Publicado: (2008)

Future therapeutic options
por: Reuser, Arnold
Publicado: (2013)

Approaching the limits: scoring functions for affinity prediction
por: Sotriffer, Christoph
Publicado: (2010)

Initiating an antimicrobial stewardship program with limited resources
por: Boyce, JM, et al.
Publicado: (2011)

Early access to medicinal products: potential and limits
por: Evers, Pauline J
Publicado: (2014)

Solvent-screening and co-crystal screening for drug development with COSMO-RS
por: Klamt, A
Publicado: (2012)

Application of bimolecular fluorescence complementation in studying the topology of polytopic proteins
por: Chang, Xingya, et al.
Publicado: (2012)

Towards a patient-based drug discovery
por: Schreiber, Stuart L
Publicado: (2012)

Influenza pandemics: past and future
por: Palese, Peter
Publicado: (2006)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Dose transition pathways: a design, analysis and operational tool for dose-finding trials using model-based designs
por: Yap, Christina, et al.
Publicado: (2015)

Limits of normality and symmetry in standing back shape and posture
por: Bettany-Saltikov, Josette, et al.
Publicado: (2010)

Hematopoietic stem cells have an intrinsic expansion limit
por: Rojas-Sutterlin, Shanti, et al.
Publicado: (2013)

Applications of RNA structure analysis to retroviral packaging and anti-retroviral therapeutic discovery
por: Weeks, Kevin M, et al.
Publicado: (2011)

Blocking protein-protein interactions: the identification of repetitive turn structures as basis for inhibitor building blocks
por: Koch, Oliver
Publicado: (2012)

Integration of chemical information with protein sequences and 3D structures
por: Golovin, Adel, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ur55r31mhk6f4vclbbtcuih041